ATAI Life Sciences N.V (NASDAQ: ATAI) kicked off on Monday, down -8.54% from the previous trading day, before settling in for the closing price of $1.99. Over the past 52 weeks, ATAI has traded in a range of $1.03-$2.85.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales drop of Healthcare Sector giant was -16.02%. While this was happening, its average annual earnings per share was recorded -216.57%. With a float of $124.98 million, this company’s outstanding shares have now reached $167.82 million.
Let’s determine the extent of company efficiency that accounts for 83 employees. In terms of profitability, gross margin is 19.64%, operating margin of -31987.01%, and the pretax margin is -38614.5%.
ATAI Life Sciences N.V (ATAI) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of ATAI Life Sciences N.V is 35.58%, while institutional ownership is 7.39%. The most recent insider transaction that took place on Feb 14 ’25, was worth 22,755,008. In this transaction 10% Owner of this company bought 10,835,718 shares at a rate of $2.10, taking the stock ownership to the 40,555,215 shares. Before that another transaction happened on Sep 26 ’24, when Company’s 10% Owner sold 2,660,000 for $6.05, making the entire transaction worth $16,093,000. This insider now owns 6,905,774 shares in total.
ATAI Life Sciences N.V (ATAI) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.15 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -216.57% per share during the next fiscal year.
ATAI Life Sciences N.V (NASDAQ: ATAI) Trading Performance Indicators
Take a look at ATAI Life Sciences N.V’s (ATAI) current performance indicators. Last quarter, stock had a quick ratio of 5.81. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1069.91.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.80, a number that is poised to hit -0.14 in the next quarter and is forecasted to reach -0.61 in one year’s time.
Technical Analysis of ATAI Life Sciences N.V (ATAI)
Looking closely at ATAI Life Sciences N.V (NASDAQ: ATAI), its last 5-days average volume was 4.85 million, which is a jump from its year-to-date volume of 3.65 million. As of the previous 9 days, the stock’s Stochastic %D was 10.10%. Additionally, its Average True Range was 0.26.
During the past 100 days, ATAI Life Sciences N.V’s (ATAI) raw stochastic average was set at 51.47%, which indicates a significant increase from 6.29% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 146.76% in the past 14 days, which was higher than the 104.15% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.6558, while its 200-day Moving Average is $1.4600. However, in the short run, ATAI Life Sciences N.V’s stock first resistance to watch stands at $1.9687. Second resistance stands at $2.1173. The third major resistance level sits at $2.2167. If the price goes on to break the first support level at $1.7207, it is likely to go to the next support level at $1.6213. Should the price break the second support level, the third support level stands at $1.4727.
ATAI Life Sciences N.V (NASDAQ: ATAI) Key Stats
The company with the Market Capitalisation of 353.07 million has total of 167,802K Shares Outstanding. Its annual sales at the moment are 310 K in contrast with the sum of -40,220 K annual income. Company’s last quarter sales were recorded 40 K and last quarter income was -26,290 K.
